[
  {
    "ts": "2026-01-27T04:36:09+00:00",
    "headline": "2 Mid-Cap Stocks with Exciting Potential and 1 We Ignore",
    "summary": "Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.",
    "url": "https://finance.yahoo.com/news/2-mid-cap-stocks-exciting-043609154.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "68fd35ec-97c8-39d5-a361-baf5c21f6b33",
      "content": {
        "id": "68fd35ec-97c8-39d5-a361-baf5c21f6b33",
        "contentType": "STORY",
        "title": "2 Mid-Cap Stocks with Exciting Potential and 1 We Ignore",
        "description": "",
        "summary": "Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.",
        "pubDate": "2026-01-27T04:36:09Z",
        "displayTime": "2026-01-27T04:36:09Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/a6e762de6dc34cf1828cdeaea57f83d3",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "GWRE Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bGk8J37YEi_AQQ4leo3d5g--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/a6e762de6dc34cf1828cdeaea57f83d3.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lsbGA9XYEkruqbIw9gDbfg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/a6e762de6dc34cf1828cdeaea57f83d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/2-mid-cap-stocks-exciting-043609154.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-mid-cap-stocks-exciting-043609154.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SWK"
            },
            {
              "symbol": "GWRE"
            },
            {
              "symbol": "DXCM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-27T13:38:40+00:00",
    "headline": "Barclays Downgrades Dexcom (DXCM) to Underweight Citing Intensifying Competition in Core Segments",
    "summary": "DexCom Inc. (NASDAQ:DXCM) is one of the best US stocks to buy and hold in 2026. On January 12, Barclays downgraded DexCom to Underweight from Equal Weight with a price target of $71, which was brought down from $80. The firm anticipated that intensifying competition within Dexcom’s primary insulin-intensive segments throughout 2026 and 2027 would […]",
    "url": "https://finance.yahoo.com/news/barclays-downgrades-dexcom-dxcm-underweight-133840838.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "e05a4091-7153-33f7-9b93-83dc951c8614",
      "content": {
        "id": "e05a4091-7153-33f7-9b93-83dc951c8614",
        "contentType": "STORY",
        "title": "Barclays Downgrades Dexcom (DXCM) to Underweight Citing Intensifying Competition in Core Segments",
        "description": "",
        "summary": "DexCom Inc. (NASDAQ:DXCM) is one of the best US stocks to buy and hold in 2026. On January 12, Barclays downgraded DexCom to Underweight from Equal Weight with a price target of $71, which was brought down from $80. The firm anticipated that intensifying competition within Dexcom’s primary insulin-intensive segments throughout 2026 and 2027 would […]",
        "pubDate": "2026-01-27T13:38:40Z",
        "displayTime": "2026-01-27T13:38:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/94a20908530176a94bb79d3c85ebc069",
          "originalWidth": 1920,
          "originalHeight": 1280,
          "caption": "Barclays Downgrades Dexcom (DXCM) to Underweight Citing Intensifying Competition in Core Segments",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aUkyuvDWR4kJ5qcXDZEZUQ--~B/aD0xMjgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/94a20908530176a94bb79d3c85ebc069.cf.webp",
              "width": 1920,
              "height": 1280,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qitlfQjFd30P6XZ4CzHJjg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/94a20908530176a94bb79d3c85ebc069.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/barclays-downgrades-dexcom-dxcm-underweight-133840838.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/barclays-downgrades-dexcom-dxcm-underweight-133840838.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DXCM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-27T13:30:00+00:00",
    "headline": "Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.",
    "summary": "SAN DIEGO, January 27, 2026--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and fiscal year 2025 financial results after market close on Thursday, February 12, 2026. Management will hold a conference call to review the company's fourth quarter and fiscal year 2025 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations webs",
    "url": "https://finance.yahoo.com/news/dexcom-schedules-fourth-quarter-fiscal-133000856.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "e36357f0-8026-38ea-8f6e-b4b7e74200f0",
      "content": {
        "id": "e36357f0-8026-38ea-8f6e-b4b7e74200f0",
        "contentType": "STORY",
        "title": "Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.",
        "description": "",
        "summary": "SAN DIEGO, January 27, 2026--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and fiscal year 2025 financial results after market close on Thursday, February 12, 2026. Management will hold a conference call to review the company's fourth quarter and fiscal year 2025 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations webs",
        "pubDate": "2026-01-27T13:30:00Z",
        "displayTime": "2026-01-27T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/d3c53d7182f1b3a60d2778f30784ff8f",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ComsqATh2M763euQflT69Q--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/d3c53d7182f1b3a60d2778f30784ff8f.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VwK6ckZcDOdyvtSjnNTi.A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/d3c53d7182f1b3a60d2778f30784ff8f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/dexcom-schedules-fourth-quarter-fiscal-133000856.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/dexcom-schedules-fourth-quarter-fiscal-133000856.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DXCM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-27T13:00:42+00:00",
    "headline": "Could 2026 Be Dexcom's 'Get Right' Year? New CEO Jake Leach Says Yes.",
    "summary": "For the first time in a decade, Dexcom has a new chief executive. And, to say Jake Leach has his work cut out for him is underselling it.",
    "url": "https://www.investors.com/news/technology/dexcom-stock-new-ceo-jake-leach-g7-15-day-stelo/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "694964c0-0cac-3bec-8efe-90ddeedb474c",
      "content": {
        "id": "694964c0-0cac-3bec-8efe-90ddeedb474c",
        "contentType": "STORY",
        "title": "Could 2026 Be Dexcom's 'Get Right' Year? New CEO Jake Leach Says Yes.",
        "description": "",
        "summary": "For the first time in a decade, Dexcom has a new chief executive. And, to say Jake Leach has his work cut out for him is underselling it.",
        "pubDate": "2026-01-27T13:00:42Z",
        "displayTime": "2026-01-27T13:00:42Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/694964c0-0cac-3bec-8efe-90ddeedb474c/could-2026-be-dexcom-s-get.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/8d992e5fea68541ab8aa369c75540705",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eCz2We1syH3XlIURbAmdRw--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/8d992e5fea68541ab8aa369c75540705.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cBwaXLERm5lXW16Pdk0aTA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/8d992e5fea68541ab8aa369c75540705.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/dexcom-stock-new-ceo-jake-leach-g7-15-day-stelo/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DXCM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]